| Literature DB >> 28721734 |
Steven A Loskot1, David K Romney1, Frances H Arnold1, Brian M Stoltz1.
Abstract
An enantioselective total synthesis of the norditerpenoid alkaloid nigelladine A is described. Strategically, the synthesis relies on a late-stage C-H oxidation of an advanced intermediate. While traditional chemical methods failed to deliver the desired outcome, an engineered cytochrome P450 enzyme was employed to effect a chemo- and regioselective allylic C-H oxidation in the presence of four oxidizable positions. The enzyme variant was readily identified from a focused library of three enzymes, allowing for completion of the synthesis without the need for extensive screening.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28721734 PMCID: PMC5679227 DOI: 10.1021/jacs.7b05196
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419